Evidence map›Paper›PMID 31777560›Full record

ArticleExperimental and therapeutic medicine2019

Probiotic and glutamine treatments attenuate alcoholic liver disease in a rat model.

Huping Huang, Zhihui Lin, Yanling Zeng, Xueyan Lin, Yali Zhang

Open access · diamondAbstract read
In one paragraph

Article in Experimental and therapeutic medicine, 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 23 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
23citing papers in PubMed, 3 pooled it
2.9field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

23 citing papers in PubMed, 3 syntheses or guidelines pooled it, 32 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Trial
  5. Article
  6. Review
  7. Review
  8. Therapeutic Potential ofJournal of microbiology and biotechnology · 2024
    Article
  9. Article
  10. Probiotics, prebiotics, and synbiotics in nonalcoholic fatty liver disease and alcohol-associated liver disease.American journal of physiology. Gastrointestinal and liver physiology · 2023
    Review
  11. Nutrients · 2022
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. Probiotics in hepatology: An update.World journal of hepatology · 2021
    Review
  18. Article
  19. Diet-Regulating Microbiota and Host Immune System in Liver Disease.International journal of molecular sciences · 2021
    Review
  20. Journal of microbiology and biotechnology · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 4 institutions in 1 country.

Huping HuangDepartment of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Zhihui LinDepartment of Gastroenterology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian 350000, P.R. China.
Yanling ZengDepartment of Gastroenterology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian 350000, P.R. China.
Xueyan LinDepartment of Gastroenterology, Fujian Provincial Hospital, Fujian Medical University, Fuzhou, Fujian 350000, P.R. China.
Yali ZhangDepartment of Gastroenterology, Nanfang Hospital, Southern Medical University, Guangzhou, Guangdong 510515, P.R. China.
Fujian Provincial Hospital · CNFujian Medical University · CNNanfang Hospital · CNSouthern Medical University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The pathogenesis underlying alcoholic liver disease (ALD), which is often a result of alcohol abuse, currently remains unclear. Previous studies have reported that enteric dysbiosis serves an important role in the pathogenesis of ALD. The present study aimed to investigate the effects of glutamine and probiotics on a rat model of alcoholic liver disease (ALD). Sixty male Sprague-Dawley rats were randomly divided into 6 groups including control (C), alcohol (M), alcohol + Golden Bifido (T), alcohol + glutamine (G), alcohol + Medilac-S

Indexed as

alcoholic liver diseaseglutaminegut microbiotaprobiotics

Identifiers

PMID31777560
PMCPMC6862500
OpenAlexW2981419052

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.